Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Outset Medical, Inc.OM · Entity 7026 | Chief Operating Officer | March 01, 2023 | March 02, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Outset Medical, Inc.
Report date March 01, 2023 · Filed March 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 108,112 |
Reported balance
After 2023-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-03-01 · Exercise / conversion · Acquired 5,000 · Balance 108,112 |
| Common StockSEC Table I · non-derivative | Direct | 103,112 |
Reported balance
After 2023-03-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-03-01 · Sale · Disposed 5,000 · Balance 103,112 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. F2: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $21.00 - $21.99 - 362 shares; $22.00 - $22.99 - 4,637 shares; $23.00 - $23.99 - 1 share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. F3: Includes 608 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c). |
| Performance Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.88 · Expires 2027-12-19 | Direct | 43,507 |
Reported balance
After 2023-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-01 · Exercise / conversion · Disposed 5,000 · Balance 43,507 F4: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.
F2: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $21.00 - $21.99 - 362 shares; $22.00 - $22.99 - 4,637 shares; $23.00 - $23.99 - 1 share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.
F3: Includes 608 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).
F4: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2022 Filed May 3, 2022 17:01 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000036 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,007 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document |
| May 02, 2022 Filed May 3, 2022 17:01 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $35.58 | $177,898.50 |
DisclosureSEC source: 0001484612-22-000036 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,495 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $34.00-$34.99 - 636 shares; $35.00-$35.99 - 3,590 shares; $36.00-$36.99 - 774 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 3, 2022 17:01 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-22-000036 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 6,500 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000030 · edgardoc.xml · derivative · entry 12 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,007 Underlying: Common Stock · 6,500 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price of one Share and (B) the Aggregate Cash Distributions is equal to or greater than $20.46 (reduced to $19.12 in 2020) on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to one greater than $20.46 (increased to $20.86 in 2020) as of the effective date of such Corporate Event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 6,500 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000030 · edgardoc.xml · derivative · entry 11 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,507 Underlying: Common Stock · 6,500 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price of one Share and (B) the Aggregate Cash Distributions is equal to or greater than $20.46 (reduced to $19.12 in 2020) on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to one greater than $20.46 (increased to $20.86 in 2020) as of the effective date of such Corporate Event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 6,668 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000030 · edgardoc.xml · derivative · entry 10 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,007 Underlying: Common Stock · 6,668 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option vests if and to the extent that (i) the sum of (A) the 30-day closing price of one Share and (B) the Aggregate Cash Distributions is equal to or greater than $20.46 (reduced to $19.12 in 2020) on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to one greater than $20.46 (increased to $20.86 in 2020) as of the effective date of such Corporate Event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 332 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000030 · edgardoc.xml · derivative · entry 9 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,743 Underlying: Common Stock · 332 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 332 | $45.81 | $15,208.75 |
DisclosureSEC source: 0001484612-22-000030 · edgardoc.xml · nonDerivative · entry 8 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,495 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $44.00-$44.99 - 200 shares; $45.00-$45.99 - 4,890 shares; $46.00 - $46.99 - 1,910 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 332 | $3.88 | $1,288.16 |
DisclosureSEC source: 0001484612-22-000030 · edgardoc.xml · nonDerivative · entry 7 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,500 | $45.77 | $297,475.75 |
DisclosureSEC source: 0001484612-22-000030 · edgardoc.xml · nonDerivative · entry 6 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,495 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. F4 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 5,012 shares; $46.00 - $46.99 - 1,488 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 6,500 | $3.88 | $25,220.00 |
DisclosureSEC source: 0001484612-22-000030 · edgardoc.xml · nonDerivative · entry 5 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,500 | $45.74 | $297,308.70 |
DisclosureSEC source: 0001484612-22-000030 · edgardoc.xml · nonDerivative · entry 4 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,495 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. F3 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $44.00-$44.99 - 100 shares; $45.00-$45.99 - 4,985 shares; $46.00 - $46.99 - 1,415 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 6,500 | $3.88 | $25,220.00 |
DisclosureSEC source: 0001484612-22-000030 · edgardoc.xml · nonDerivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,668 | $45.81 | $305,457.75 |
DisclosureSEC source: 0001484612-22-000030 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,495 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $44.00-$44.99 - 200 shares; $45.00-$45.99 - 4,890 shares; $46.00 - $46.99 - 1,910 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:15 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 6,668 | $3.88 | $25,871.84 |
DisclosureSEC source: 0001484612-22-000030 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2022 Filed Mar 16, 2022 17:38 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,030 | $39.77 | $40,963.10 |
DisclosureSEC source: 0001484612-22-000026 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,495 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 2,064 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 16:47 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001484612-22-000019 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,151 Underlying: Common Stock · 5,000 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests in 48 equal monthly installments beginning on March 3, 2020, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 16:47 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $43.51 | $217,558.50 |
DisclosureSEC source: 0001484612-22-000019 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,525 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $42.00-$42.99 - 745 shares; $43.00-$43.99 - 3,355 shares; $44.00 - $44.99 - 900 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 16:47 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $8.62 | $43,100.00 |
DisclosureSEC source: 0001484612-22-000019 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 16:11 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0001484612-22-000017 · edgardoc.xml · derivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,151 Underlying: Common Stock · 5,000 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests in 48 equal monthly installments beginning on March 3, 2020, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 16:11 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $37.44 | $187,198.00 |
DisclosureSEC source: 0001484612-22-000017 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,525 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $36.00-$36.99 - 700 shares; $37.00-$37.99 - 4,146 shares; $38.00-$38.99 - 154 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 16:11 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $8.62 | $43,100.00 |
DisclosureSEC source: 0001484612-22-000017 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 17:01 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 2,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000014 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,525 F2 · shares: Represents portion of stock units granted to the reporting person on January 26, 2022 that will vest on December 31, 2024, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 17:01 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 39,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000014 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,327 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 26, 2022. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 26, 2023, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionPerformance Options (right to buy) · Derivative | 3,208 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · derivative · entry 15 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,675 Underlying: Common Stock · 3,208 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option vests if and to the extent that (1) the sum of (A) the 30-day closing price trading average of one share and (b) the aggregate amount of cash distributed with respect to one share (the "Aggregate Cash Distributions") is equal to or greater than $28.52 (reduced to $20.46) on any day following the expiration of the post-offering lock-up period or (11) the sum of (x) the value of all consideration that is distributable with respect to one Share in connection with a "Corporate Event" (as defined in the Outset Medical Amended and Restated 2010 Stock Incentive Plan (the "2010 Plan) and (Y) the Aggregate Cash Distribution is equal to or greater than $28.52 (reduced to $20.46 in 2020) as of the effective date of each Corporate Event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $4.11 | $0.00 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · derivative · entry 14 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,204 Underlying: Common Stock · 6,000 shares Expires 2028-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option vests in 48 equal monthly installments beginning on December 3, 2018, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $4.11 | $0.00 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · derivative · entry 13 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,204 Underlying: Common Stock · 5,000 shares Expires 2028-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option vests in 48 equal monthly installments beginning on December 3, 2018, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,378 | $0.00 Strike: $4.11 | $0.00 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · derivative · entry 12 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,204 Underlying: Common Stock · 1,378 shares Expires 2028-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option vests in 48 equal monthly installments beginning on December 3, 2018, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 414 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · derivative · entry 11 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,075 Underlying: Common Stock · 414 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,000 | $47.07 | $282,401.40 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · nonDerivative · entry 10 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 430 shares; $46.00-$46.99 - 964 shares; $47.00-$47.99 - 4,430 shares; $48.00 - $48.99 - 176 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 6,000 | $4.11 | $24,660.00 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · nonDerivative · entry 9 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $47.05 | $235,229.50 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · nonDerivative · entry 8 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 400 shares; $46.00-$46.99 - 854 shares; $47.00-$47.99 - 3,546 shares; $48.00 - $48.99 - 200 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $4.11 | $20,550.00 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · nonDerivative · entry 7 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 414 | $47.04 | $19,474.31 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · nonDerivative · entry 6 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 400 shares; $46.00-$46.99 - 854 shares; $47.00-$47.99 - 3,746 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 414 | $3.88 | $1,606.32 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · nonDerivative · entry 5 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,378 | $47.04 | $64,820.29 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · nonDerivative · entry 4 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 400 shares; $46.00-$46.99 - 854 shares; $47.00-$47.99 - 3,746 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 1,378 | $4.11 | $5,663.58 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · nonDerivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,208 | $47.04 | $150,902.40 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 400 shares; $46.00-$46.99 - 854 shares; $47.00-$47.99 - 3,746 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:59 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 3,208 | $3.88 | $12,447.04 |
DisclosureSEC source: 0001484612-22-000006 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 18:16 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,500 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000073 · edgardoc.xml · derivative · entry 6 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,489 Underlying: Common Stock · 6,500 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 18:16 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000073 · edgardoc.xml · derivative · entry 5 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,989 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 18:16 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 6,500 | $55.00 | $357,500.00 |
DisclosureSEC source: 0001484612-21-000073 · edgardoc.xml · nonDerivative · entry 4 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 18:16 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 6,500 | $3.88 | $25,220.00 |
DisclosureSEC source: 0001484612-21-000073 · edgardoc.xml · nonDerivative · entry 3 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 18:16 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $57.43 | $287,171.00 |
DisclosureSEC source: 0001484612-21-000073 · edgardoc.xml · nonDerivative · entry 2 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $54.00-$54.99 - 166 shares; $55.00-$55.99 - 100 shares; $56.00-$56.99 - 1,504 shares; $57.00-$57.99 - 1,664 shares; $58.00-$58.99 - 1,566 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 18:16 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-21-000073 · edgardoc.xml · nonDerivative · entry 1 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 16:22 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000068 · edgardoc.xml · derivative · entry 9 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,989 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 16:22 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000068 · edgardoc.xml · derivative · entry 8 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,989 Underlying: Common Stock · 5,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 16:22 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001484612-21-000068 · edgardoc.xml · derivative · entry 7 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,989 Underlying: Common Stock · 6,000 shares Expires 2027-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 16:22 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,000 | $48.72 | $243,587.50 |
DisclosureSEC source: 0001484612-21-000068 · edgardoc.xml · nonDerivative · entry 6 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,255 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $47.77 to $49.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 16:22 UTC | Outset Medical, Inc. OM · Entity 7026 | Exercise / conversionCommon Stock | 5,000 | $3.88 | $19,400.00 |
DisclosureSEC source: 0001484612-21-000068 · edgardoc.xml · nonDerivative · entry 5 Vazquez Martin · CIK 0001823380 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.